Your session is about to expire
← Back to Search
Allograft Tissue Implant
Allograft Tissue for Vertebral Compression Fractures
N/A
Waitlist Available
Research Sponsored by Lenoss Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial is testing whether using allograft tissue to fill bone voids is effective in reducing pain for patients with vertebral compression fractures.
Eligible Conditions
- Vertebral Compression Fractures
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evaluate fracture stability assessed via subject- reported pain over time
Secondary outcome measures
Frequency of Implant Related Complications
Measure of Physical Disability Assessed via the Roland Morris Disability Questionnaire
Measurement of Activities of Daily Living Assessed via the Modified Tegner Activity Level Scale
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Allograft TissueExperimental Treatment2 Interventions
Allograft tissue product for patients with painful vertebral compression fractures
Find a Location
Who is running the clinical trial?
MCRAIndustry Sponsor
29 Previous Clinical Trials
9,130 Total Patients Enrolled
Lenoss MedicalLead Sponsor
MCRA, LLCIndustry Sponsor
18 Previous Clinical Trials
7,697 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger